Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation

NCT06584266 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2024-09-04

No results posted yet for this study

Summary

The goal of this observational registry is to collect a curated dataset of multimodal imaging data that will serve for development of artificial-intelligence based solutions for prediction of risk and outcomes in patients with atrial fribrillation.

Type of study: observational study

Study Participants: Patients with atrial fibrillation or atrial flutter who undergo clinically indicated transesophageal echocardiography before catheter ablation or cardioversion.

We hypothesize, that automatic analysis of video images of transthoracic echocardiography with deep learning combined with clinical data can predict the presence of left atrial appendage thrombus (LAT). Therefore, our main aim is to create and validate an artificial intelligence model to predict the presence of LAT based on automatic analysis of transthoracic echocardiography with artificial intelligence.

Conditions

  • Atrial Fibrillation and Flutter
  • Heart Failure
  • Artificial Intelligence (AI)
  • Echocardiography

Interventions

DIAGNOSTIC_TEST

Transoesophageal echocardiography

Imaging data obtained with transoesophageals echocardiography will be retained as well as data from transthoracic echocardiography and from other imaging modalities, if available

PROCEDURE

Catheter ablation

Cathether ablation of atrial fibrillation substrate using one of available methods.

Sponsors & Collaborators

  • Military Institute od Medicine National Research Institute

    collaborator OTHER
  • National Institute of Cardiology, Warsaw, Poland

    collaborator OTHER
  • Medical University of Silesia, Katowice, Poland

    collaborator UNKNOWN
  • St. Anne's University Hospital Brno, Czech Republic

    collaborator OTHER
  • John Paul II Hospital, Krakow

    collaborator OTHER
  • Nowa Sol Multidyscyplinary Hospital, Poland

    collaborator UNKNOWN
  • University in Zielona Góra

    lead OTHER

Principal Investigators

  • Konrad Pieszko, MD, PhD · University of Zielona Gora

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2026-09-30
Completion
2027-09-30

Countries

  • Czechia
  • Poland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06584266 on ClinicalTrials.gov